The Role of Liposomal Bupivacaine in Multimodal Pain Management Following Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis
Authors:
- 1 May 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Spine
- Vol. 49 (2) , E11-E16
Abstract
Study Design.: Retrospective controlled cohort. Objective.: To evaluate the effect of intraoperative liposomal bupivacaine (LB) infiltration on postsurgical pain management in adolescent idiopathic scoliosis (AIS) patients by analyzing postoperative opioid consumption, ambulation, and length of stay (LOS). Summary of Background Data.: Optimal postoperative pain control for AIS patients undergoing posterior spinal fusion (PSF) is challenging. Multimodal pain management protocols provide adequate analgesia while decreasing opioid consumption. LB was recently approved for pediatric patients; however, use in AIS patients is understudied. Methods.: 119 consecutive patients with AIS who underwent PSF were included. Patients were divided into 2 groups: patients who received LB as erector spinae block in addition to the standard postoperative pain management protocol (Group A), and patients who received only the standard postoperative pain protocol (Group B). Oral morphine equivalents, intravenous opioid and valium consumption, pain scores (VAS), nausea/vomiting, ambulation distance and LOS were assessed. Results.: Group A experienced significantly lower total opioid consumption compared to Group B (44.5 mg vs. 70.2 mg). Morphine use was lower in Group A on postoperative day (POD) 0, and oxycodone use was lower in Group A on PODs 1 and 2. There was a higher proportion of patients who used only oral opioids in Group A (81% vs. 41%). Of patients requiring any intravenous opioids, 79% did not receive LB. A significantly higher proportion of LB patients were discharged on POD 2 (55% vs. 27%); therefore, LOS was shorter for Group A. Group A ambulated further postoperatively. There were no differences in pain scores, valium requirements or nausea/vomiting. Conclusions.: LB was associated with decreased total opioid use, shorter LOS, and improved ambulation in AIS patients undergoing PSF. Including LB in multimodal pain management protocols proved effective in reducing opioid use while increasing mobilization in the immediate postoperative period. Level of Evidence.: 3.Keywords
This publication has 17 references indexed in Scilit:
- Multimodal pain control in adolescent posterior spinal fusion patients: a double-blind, randomized controlled trial to validate the effect of gabapentin on postoperative pain control, opioid use, and patient satisfactionSpine Deformity, 2020
- Quality improvement in post-operative opioid and benzodiazepine regimen in adolescent patients after posterior spinal fusionSpine Deformity, 2020
- Preemptive Pregabalin in Children and Adolescents Undergoing Posterior Instrumented Spinal FusionJournal of Bone and Joint Surgery, 2019
- Current Trends in Pediatric Spine Deformity Surgery: Multimodal Pain Management and Rapid RecoveryGlobal Spine Journal, 2019
- Effectiveness and Sustainability of a Standardized Care Pathway Developed with Use of Lean Process Mapping for the Treatment of Patients Undergoing Posterior Spinal Fusion for Adolescent Idiopathic ScoliosisJournal of Bone and Joint Surgery, 2018
- Does Subcutaneous Infiltration of Liposomal Bupivacaine Following Single-Level Transforaminal Lumbar Interbody Fusion Surgery Improve Immediate Postoperative Pain Control?Asian Spine Journal, 2018
- The Role of Liposomal Bupivacaine in Reduction of Postoperative Pain After Transforaminal Lumbar Interbody Fusion: A Clinical StudyWorld Neurosurgery, 2016
- Periarticular Injection After Total Knee Arthroplasty Using Liposomal Bupivacaine vs a Modified Ranawat Suspension: A Prospective, Randomized StudyThe Journal of Arthroplasty, 2016
- Adolescent idiopathic scoliosisThe Lancet, 2008
- Results of Charleston Bracing in Skeletally Immature Patients With Idiopathic ScoliosisJournal of Pediatric Orthopaedics, 2001